(株)メドレックスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4586/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/04/28 | 日証協 | 795,301株 | +8.29% | 146,801株 | -22.61% | 635,425株 | +3.43% | 114,800株 | -8.67% |
2017/04/21 | 日証協 | 734,401株 | -1.91% | 189,702株 | -33.81% | 614,325株 | -11.55% | 125,700株 | -13.74% |
2017/04/14 | 日証協 | 748,701株 | +19.95% | 286,602株 | +82.78% | 694,535株 | +12.09% | 145,730株 | +153.44% |
2017/04/07 | 日証協 | 624,201株 | -0.16% | 156,800株 | +24.25% | 619,605株 | +6.99% | 57,500株 | -44.84% |
2017/03/31 | 日証協 | 625,201株 | -2.43% | 126,201株 | +159.67% | 579,101株 | -7.41% | 104,244株 | +520.5% |
2017/03/24 | 日証協 | 640,801株 | -4.94% | 48,600株 | -67.77% | 625,466株 | -7.5% | 16,800株 | -88.7% |
2017/03/17 | 日証協 | 674,101株 | +23.1% | 150,801株 | +129.88% | 676,166株 | +20.32% | 148,700株 | +139.84% |
2017/03/10 | 日証協 | 547,601株 | +9% | 65,601株 | -0.15% | 561,966株 | +7.97% | 62,000株 | +28.36% |
2017/03/03 | 日証協 | 502,401株 | +4.39% | 65,697株 | +49.47% | 520,466株 | -1.05% | 48,300株 | -39.88% |
2017/02/24 | 日証協 | 481,257株 | -3.74% | 43,953株 | +292.37% | 525,966株 | +6.01% | 80,344株 | -27.2% |
2017/02/17 | 日証協 | 499,951株 | -36.17% | 11,202株 | -92.45% | 496,166株 | -23.12% | 110,370株 | -21.83% |
2017/02/10 | 日証協 | 783,251株 | +4.89% | 148,382株 | +1530.39% | 645,379株 | +2.93% | 141,193株 | +1172.01% |
2017/02/03 | 日証協 | 746,706株 | -0.74% | 9,101株 | +37.87% | 627,011株 | 0% | 11,100株 | +4.72% |
2017/01/27 | 日証協 | 752,306株 | -0.17% | 6,601株 | -69.44% | 627,011株 | -0.18% | 10,600株 | +100% |
2017/01/20 | 日証協 | 753,606株 | +1.07% | 21,601株 | -36.84% | 628,111株 | +1.18% | 5,300株 | -67.48% |
2017/01/13 | 日証協 | 745,605株 | +1.75% | 34,200株 | +167.19% | 620,811株 | +1.09% | 16,299株 | +225.98% |
2017/01/06 | 日証協 | 732,805株 | -1.39% | 12,800株 | -86.3% | 614,111株 | +5.19% | 5,000株 | -91.94% |
2016/12/30 | 日証協 | 743,105株 | +2.09% | 93,400株 | +212.37% | 583,806株 | -6.57% | 62,005株 | +532.32% |
2016/12/22 | 日証協 | 727,905株 | +2.68% | 29,900株 | -22.74% | 624,840株 | +1.92% | 9,806株 | -45.2% |
※株式分割は考慮していませんのでご注意ください。
Page Top